Arbutus Biopharma Corp Basic Shares Outstanding (Weighted Average)
Arbutus Biopharma Corp (ABUS) reported Basic Shares Outstanding (Weighted Average) of 197.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 197.47M shares, a 3.09% increase year-over-year.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 193.77M shares, a 1.61% increase year-over-year.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 192.35M shares, a 1.40% increase year-over-year.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 191.78M shares, a 1.47% increase year-over-year.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for fiscal 2025 was 191.60M shares, a 3.23% increase from fiscal 2024.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for fiscal 2024 was 185.61M shares, a 11.84% increase from fiscal 2023.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for fiscal 2023 was 165.96M shares, a 9.95% increase from fiscal 2022.
- Arbutus Biopharma Corp weighted average number of shares outstanding, basic for fiscal 2022 was 150.94M shares, a 42.07% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 197.47M shares 10-Q · filed 2026-08-12 | 195.63M shares 10-Q · filed 2026-08-12 | 194.53M shares derived: average of 3 quarters · filed 2026-08-12 | 193.84M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 193.77M shares 10-Q · filed 2026-05-13 | 193.06M shares derived: average of 2 quarters · filed 2026-05-13 | 192.63M shares derived: average of 3 quarters · filed 2026-05-13 | 192.36M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 192.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 192.07M shares derived: average of 2 quarters · filed 2026-03-23 | 191.89M shares derived: average of 3 quarters · filed 2026-08-12 | 191.60M shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 191.78M shares 10-Q · filed 2025-11-13 | 191.67M shares derived: average of 2 quarters · filed 2026-08-12 | 191.35M shares 10-Q · filed 2025-11-13 | 190.93M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 191.55M shares 10-Q · filed 2026-08-12 | 191.13M shares 10-Q · filed 2026-08-12 | 190.65M shares derived: average of 3 quarters · filed 2026-08-12 | 190.24M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 190.71M shares 10-Q · filed 2026-05-13 | 190.20M shares derived: average of 2 quarters · filed 2026-05-13 | 189.80M shares derived: average of 3 quarters · filed 2026-05-13 | 189.36M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 189.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 189.35M shares derived: average of 2 quarters · filed 2026-03-23 | 188.91M shares derived: average of 3 quarters · filed 2026-03-23 | 185.61M shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 189.00M shares 10-Q · filed 2025-11-13 | 188.52M shares derived: average of 2 quarters · filed 2025-11-13 | 184.24M shares 10-Q · filed 2025-11-13 | 180.31M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 188.04M shares 10-Q · filed 2025-08-06 | 181.84M shares 10-Q · filed 2025-08-06 | 177.42M shares derived: average of 3 quarters · filed 2025-08-06 | 174.94M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 175.63M shares 10-Q · filed 2025-05-14 | 172.11M shares derived: average of 2 quarters · filed 2025-05-14 | 170.57M shares derived: average of 3 quarters · filed 2025-05-14 | 169.45M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 168.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 168.05M shares derived: average of 2 quarters · filed 2025-03-27 | 167.39M shares derived: average of 3 quarters · filed 2025-03-27 | 165.96M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 167.51M shares 10-Q · filed 2024-11-06 | 166.79M shares derived: average of 2 quarters · filed 2024-11-06 | 165.09M shares 10-Q · filed 2024-11-06 | 162.70M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 166.06M shares 10-Q · filed 2024-08-08 | 163.86M shares 10-Q · filed 2024-08-08 | 161.10M shares derived: average of 3 quarters · filed 2024-08-08 | 158.58M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 161.64M shares 10-Q · filed 2024-05-02 | 158.62M shares derived: average of 2 quarters · filed 2024-05-02 | 156.08M shares derived: average of 3 quarters · filed 2024-05-02 | 154.25M shares derived: average of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | 155.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 153.30M shares derived: average of 2 quarters · filed 2024-03-05 | 151.78M shares derived: average of 3 quarters · filed 2024-03-05 | 150.94M shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 151.00M shares 10-Q · filed 2023-11-07 | 149.87M shares derived: average of 2 quarters · filed 2023-11-07 | 149.39M shares 10-Q · filed 2022-11-09 | 145.41M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 148.75M shares 10-Q · filed 2023-08-03 | 148.59M shares 10-Q · filed 2022-08-04 | 143.54M shares derived: average of 3 quarters · filed 2023-08-03 | 132.98M shares derived: average of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 148.43M shares 10-Q · filed 2023-05-04 | 140.94M shares derived: average of 2 quarters · filed 2023-05-04 | 127.72M shares derived: average of 3 quarters · filed 2023-05-04 | 120.01M shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 133.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 117.37M shares derived: average of 2 quarters · filed 2023-03-02 | 110.53M shares derived: average of 3 quarters · filed 2023-03-02 | 106.24M shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 101.29M shares 10-Q · filed 2022-11-09 | 99.08M shares derived: average of 2 quarters · filed 2022-11-09 | 97.17M shares 10-Q · filed 2022-11-09 | 94.48M shares derived: average of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 96.87M shares 10-Q · filed 2022-08-04 | 95.15M shares 10-Q · filed 2022-08-04 | 92.21M shares derived: average of 3 quarters · filed 2022-08-04 | 89.03M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 93.43M shares 10-Q · filed 2022-05-05 | 89.87M shares derived: average of 2 quarters · filed 2022-05-05 | 86.41M shares derived: average of 3 quarters · filed 2022-05-05 | 82.21M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 86.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 82.90M shares derived: average of 2 quarters · filed 2022-03-03 | 78.47M shares derived: average of 3 quarters · filed 2022-03-03 | 75.84M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 79.49M shares 10-Q · filed 2021-11-04 | 74.55M shares derived: average of 2 quarters · filed 2021-11-04 | 72.34M shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 69.60M shares 10-Q · filed 2021-08-05 | 68.66M shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 67.68M shares 10-Q · filed 2021-05-05 | |||
| 2019-06-30 | 56.81M shares 10-Q · filed 2019-08-05 | 56.28M shares 10-Q · filed 2019-08-05 | ||
| 2018-12-31 | 55.30M shares 10-K · filed 2019-03-07 | |||
| 2018-06-30 | 55.21M shares 10-Q · filed 2019-08-05 | 55.15M shares 10-Q · filed 2019-08-05 | ||
| 2017-12-31 | 54.72M shares 10-K · filed 2019-03-07 | |||
| 2017-06-30 | 54.65M shares 10-Q · filed 2018-08-03 | 54.48M shares 10-Q · filed 2018-08-03 | ||
| 2016-12-31 | 53.07M shares 10-K · filed 2018-03-16 | |||
| 2015-12-31 | 45.46M shares 10-K · filed 2018-03-16 | |||
| 2015-03-31 | 30.21M shares 10-Q · filed 2015-05-06 | |||
| 2014-12-31 | 21.60M shares 10-K · filed 2017-03-22 | |||
| 2014-03-31 | 19.80M shares 10-Q · filed 2015-05-06 | |||
| 2013-12-31 | 15.30M shares 10-K · filed 2016-03-09 | |||
| 2012-12-31 | 13.73M shares 10-K · filed 2015-03-13 | |||
| 2011-12-31 | 11.32M shares 10-K · filed 2014-03-28 | |||
| 2010-12-31 | 10.33M shares 20-F · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |